FDA Inspection 1243672 — David Brabham, D.O.
The FDA completed an inspection of David Brabham, D.O. on Jun 28, 2024 in Amarillo, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 28, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Amarillo, TX (United States)
Additional Details
Clinical Investigator (CI)